ESPE Abstracts

^aBarts and the London School of Medicine and Dentistry, William Harvey Research Institute, Centre for Endocrinology, Queen Mary University of London, London, UK; ^bMedical Research Council (MRC) Harwell, Diabetes Group, Harwell Science and Innovation Campus, Oxfordshire, UK; ^cCentre for Endocrinology, Diabetes and Metabolism (CEDAM), School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, UK

Inserm U1141, Paris Diderot University, 75019 Paris, France

Prometheon Pharma, LLC, Alachua, Florida, USA

Department of Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden

^aPaediatric Endocrinology, University Children’s Hospital, Tübingen, Germany; ^bInstitute of Human Genetics, University Hospital, RWTH University Aachen, Aachen, Germany; ^cGeneticum, Genetic Counseling and Diagnostics, Stuttgart, Germany; ^dDepartment of Clinical Genetics, LUMC, Leiden, The Netherlands; ^eDepartment of Pediatrics and Neuropediatrics, SLK Klnikum, Heilbronn, Germany; ^fServiceXS B.V., Leiden, The Netherlands; ^gGenomeScan B.V., Leiden, The Netherlands; ^hLigandisGbR, Gülzow-Prüzen, Germany; ⁱDepartment of Pediatrics and Neuropediatrics, University Medicine, Göttingen, Germany

University of Michigan, Ann Arbor, Michigan, USA